Irene De Francesco
Irene De Francesco
Guy’s and St Thomas’ NHS Foundation Trust
Nessuna email verificata
Citata da
Citata da
Cytokines expression in SLE nephritis
A Gigante, ML Gasperini, A Afeltra, B Barbano, D Margiotta, R Cianci, ...
Eur Rev Med Pharmacol Sci 15 (1), 15-24, 2011
Development of clinical simultaneous SPECT/MRI
FC Hutton BF, Occhipinti M, Kuehne A, Mth D, Kovcs N, Waiczies H ...
Br J Radiol., 2017
Revascularization versus medical therapy for renal artery stenosis: antihypertensive drugs and renal outcome
R Cianci, P Martina, F Borghesi, D di Donato, L Polidori, S Lai, G Ascoli, ...
Angiology 62 (1), 92-99, 2011
Intensity-modulated radiotherapy and anal cancer: clinical outcome and late toxicity assessment
I De Francesco, K Thomas, L Wedlake, D Tait
Clinical oncology 28 (9), 604-610, 2016
Nephroangiosclerosis and its pharmacological approach
R Cianci, B Barbano, P Martina, A Gigante, L Polidori, S Lai, G Ascoli, ...
Current vascular pharmacology 9 (2), 238-243, 2011
Solitary rib metastasis of nasopharyngeal carcinoma
F De Felice, D Musio, AL Magnante, N Bulzonetti, I De Francesco, ...
Chinese Journal of Cancer Research 26 (2), 219, 2014
Diffusion-weighted magnetic resonance imaging in painful bone metastases: Using quantitative apparent diffusion coefficient as an indicator of effectiveness of single fraction…
D Musio, I De Francesco, A Galdieri, C Marsecano, A Piciocchi, A Napoli, ...
European Journal of Radiology 98, 1-6, 2018
Penile Kaposi’s Sarcoma
V Grandi, I De Francesco
New England Journal of Medicine 382 (12), e20, 2020
INSERT: A novel clinical scanner for simultaneous SPECT/MRI brain studies
BF Hutton, K Erlandsson, D Salvado, M Occhipinti, Z Papp, B Tlgyesi, ...
2017 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC…, 2017
Pelvic Intensity-modulated Radiotherapy: Can we Better Quantify the Late Side-effects?
TDM De Francesco I, Thomas K
Clinical Oncology (Royal College of Radiologist) 27 (7), 428, 2015
A case of cutaneous peripheral T-cell not otherwise specified (PTCL-NOS), successfully treated with brentuximab vedotin after disease progression on standard chemotherapy
I De Francesco, M Wain, D Wong, F Child, D Dasgupta, S Whittaker, ...
European Journal of Cancer 156, S57-S58, 2021
PO-1078 HDR brachytherapy for treatment of primary cutaneous lymphoma at complex sites and curved surfaces
V Sim, I De Francesco, S Whittaker, F Child, M Wain, S Aldridge, E Jones, ...
Radiotherapy and Oncology 161, S896-S897, 2021
Dosimetric comparison of brachytherapy and Tomotherapy for a large SCC on the scalp
RG Vaz, E Jones, R Begum, A Dobson, S Morris, I De Francesco
Radiotherapy and Oncology 158, S219-S220, 2021
Non-Melanoma Skin Cancer
I De Francesco, S Whittaker, SL Morris
Treatment of Cancer, 375-409, 2020
Treatment of mycosis fungoides/Sezary syndrome with brentuximab vedotin on the compassionate use program and CDF: outcomes and toxicities
S Enefer, V Grandi, I De Francesco, S Morris
European Journal of Cancer 119, S29, 2019
Integrated SPECT-MRI for enhanced stratification and early treatment response assessment in glioma
S Short, B Hutton, L Ottobrini, I De Francesco, C Fiorini
Neuro-Oncology 20 (Suppl 1), i2, 2018
Results of radical chemoradiotherapy for oesophageal and junctional cancers: The Royal Marsden Hospital experience
L Bernier, I De Francesco, D Tait
European Journal of Cancer 1 (72), S82, 2017
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–17